12-2120316-C-G
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_000719.7(CACNA1C):c.372-9C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,407,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000719.7 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.372-9C>G | intron_variant | Intron 2 of 46 | 5 | NM_001167623.2 | ENSP00000382512.1 | |||
CACNA1C | ENST00000399655.6 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | NM_000719.7 | ENSP00000382563.1 | |||
CACNA1C | ENST00000682544.1 | c.462-9C>G | intron_variant | Intron 2 of 49 | ENSP00000507184.1 | |||||
CACNA1C | ENST00000406454.8 | c.372-9C>G | intron_variant | Intron 2 of 47 | 5 | ENSP00000385896.3 | ||||
CACNA1C | ENST00000399634.6 | c.372-9C>G | intron_variant | Intron 2 of 46 | 5 | ENSP00000382542.2 | ||||
CACNA1C | ENST00000683824.1 | c.462-9C>G | intron_variant | Intron 2 of 47 | ENSP00000507867.1 | |||||
CACNA1C | ENST00000347598.9 | c.372-9C>G | intron_variant | Intron 2 of 48 | 1 | ENSP00000266376.6 | ||||
CACNA1C | ENST00000344100.7 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000341092.3 | ||||
CACNA1C | ENST00000327702.12 | c.372-9C>G | intron_variant | Intron 2 of 47 | 1 | ENSP00000329877.7 | ||||
CACNA1C | ENST00000399617.6 | c.372-9C>G | intron_variant | Intron 2 of 47 | 5 | ENSP00000382526.1 | ||||
CACNA1C | ENST00000682462.1 | c.462-9C>G | intron_variant | Intron 2 of 46 | ENSP00000507105.1 | |||||
CACNA1C | ENST00000683781.1 | c.462-9C>G | intron_variant | Intron 2 of 46 | ENSP00000507434.1 | |||||
CACNA1C | ENST00000683840.1 | c.462-9C>G | intron_variant | Intron 2 of 46 | ENSP00000507612.1 | |||||
CACNA1C | ENST00000683956.1 | c.462-9C>G | intron_variant | Intron 2 of 46 | ENSP00000506882.1 | |||||
CACNA1C | ENST00000399638.5 | c.372-9C>G | intron_variant | Intron 2 of 47 | 1 | ENSP00000382547.1 | ||||
CACNA1C | ENST00000335762.10 | c.372-9C>G | intron_variant | Intron 2 of 47 | 5 | ENSP00000336982.5 | ||||
CACNA1C | ENST00000399606.5 | c.372-9C>G | intron_variant | Intron 2 of 47 | 1 | ENSP00000382515.1 | ||||
CACNA1C | ENST00000399621.5 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000382530.1 | ||||
CACNA1C | ENST00000399637.5 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000382546.1 | ||||
CACNA1C | ENST00000402845.7 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000385724.3 | ||||
CACNA1C | ENST00000399629.5 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000382537.1 | ||||
CACNA1C | ENST00000682336.1 | c.372-9C>G | intron_variant | Intron 2 of 46 | ENSP00000507898.1 | |||||
CACNA1C | ENST00000399591.5 | c.372-9C>G | intron_variant | Intron 2 of 45 | 1 | ENSP00000382500.1 | ||||
CACNA1C | ENST00000399595.5 | c.372-9C>G | intron_variant | Intron 2 of 45 | 1 | ENSP00000382504.1 | ||||
CACNA1C | ENST00000399649.5 | c.372-9C>G | intron_variant | Intron 2 of 45 | 1 | ENSP00000382557.1 | ||||
CACNA1C | ENST00000399597.5 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000382506.1 | ||||
CACNA1C | ENST00000399601.5 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000382510.1 | ||||
CACNA1C | ENST00000399641.6 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000382549.1 | ||||
CACNA1C | ENST00000399644.5 | c.372-9C>G | intron_variant | Intron 2 of 46 | 1 | ENSP00000382552.1 | ||||
CACNA1C | ENST00000682835.1 | c.372-9C>G | intron_variant | Intron 2 of 46 | ENSP00000507282.1 | |||||
CACNA1C | ENST00000683482.1 | c.372-9C>G | intron_variant | Intron 2 of 46 | ENSP00000507169.1 | |||||
CACNA1C | ENST00000682686.1 | c.372-9C>G | intron_variant | Intron 2 of 45 | ENSP00000507309.1 | |||||
CACNA1C | ENST00000682152.1 | c.321-9C>G | intron_variant | Intron 1 of 5 | ENSP00000506759.1 | |||||
CACNA1C | ENST00000480911.6 | n.372-9C>G | intron_variant | Intron 2 of 26 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000923 AC: 23AN: 249224Hom.: 0 AF XY: 0.0000888 AC XY: 12AN XY: 135162
GnomAD4 exome AF: 0.0000287 AC: 36AN: 1255226Hom.: 0 Cov.: 19 AF XY: 0.0000157 AC XY: 10AN XY: 636026
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152306Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74470
ClinVar
Submissions by phenotype
not specified Benign:1
Variant summary: CACNA1C c.372-9C>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 3/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 9.2e-05 in 249224 control chromosomes, predominantly at a frequency of 0.0012 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 120-fold the estimated maximal expected allele frequency for a pathogenic variant in CACNA1C causing Timothy Syndrome phenotype (1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.372-9C>G has been reported in the literature in at least one individual affected with atrioventricular block (e.g. Liu_2017). This report does not provide unequivocal conclusions about association of the variant with Timothy Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted a clinical significance assessment for this variant to ClinVar after 2014 without evidence for independent evaluation and cited the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -
not provided Benign:1
This variant is associated with the following publications: (PMID: 28878402) -
Long QT syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at